26 Results for "

Nintedanib

" in MedChemExpress (MCE) Product Catalog:
Products (26)

26 Results for "Nintedanib" in MCE Product Catalog:

73
73 Publications Verification
Cat. No.: HY-50904
CAS No.: 656247-17-5
Synonyms: BIBF 1120
Target:  

PDGFR VEGFR FGFR

Research Areas:  

Cancer

Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
73
73 Publications Verification
Cat. No.: HY-11106
CAS No.: 656247-18-6
Purity:  99.96%
Synonyms: BIBF 1120 esylate
Target:  

PDGFR VEGFR FGFR

Research Areas:  

Cancer

Nintedanib esylate (BIBF 1120 esylate) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
1
1 Cited Publications
Cat. No.: HY-15992
CAS No.: 894783-71-2
Target:  

VEGFR

Research Areas:  

Cancer

BIBF 1202 is the carboxylate metabolite of Nintedanib (HY-50904) which inhibits VEGFR2 kinase with an IC50 of 62 nM.
Cat. No.: HY-50904S2
CAS No.: 1624587-87-6
Synonyms: BIBF 1120-d8
Nintedanib-d8 is deuterium labeled Nintedanib. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
Cat. No.: HY-Z0022
CAS No.: 380427-39-4
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 4 is an impurity of Nintedanib (HY-50904).
Cat. No.: HY-I1232
CAS No.: 1160293-25-3
Synonyms: Nintedanib-018
Target:  

Drug Intermediate

Research Areas:  

Others

Methyl 1-(2-chloroacetyl)-2-oxoindoline-6-carboxylate (Nintedanib-018) is a drug intermediate for synthesis of various active compounds.
Cat. No.: HY-Z0128
CAS No.: 1092522-02-5
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 9 is an impurity of Nintedanib (HY-50904).
Cat. No.: HY-50904S1
Synonyms: BIBF 1120-13C,d3
Nintedanib- 13C,d3 is the 13C- and deuterium labeled Nintedanib. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
Cat. No.: HY-50904R
CAS No.: 656247-17-5
Synonyms: BIBF 1120 (Standard)
Research Areas:  

Cancer

Nintedanib (Standard) is the analytical standard of Nintedanib. This product is intended for research and analytical applications. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
Cat. No.: HY-50904S
CAS No.: 1624587-84-3
Synonyms: BIBF 1120-d3
Nintedanib-d3 is the deuterium labeled Nintedanib. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
Cat. No.: HY-11106R
CAS No.: 656247-18-6
Synonyms: BIBF 1120 esylate (Standard)
Research Areas:  

Cancer

Nintedanib esylate (Standard) is the analytical standard of Nintedanib esylate. This product is intended for research and analytical applications. Nintedanib esylate (BIBF 1120 esylate) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
Cat. No.: HY-Z0013R
CAS No.: 1987887-92-2
Target:  

Reference Standards

(Z)-Methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (Nintedanib Impurity) (Standard) is the analytical standard of (Z)-Methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (Nintedanib Impurity). This product is intended for research and analytical applications.
Cat. No.: HY-Z0127R
CAS No.: 474020-88-7
Target:  

Reference Standards

tert-Butyl Methyl(4-nitrophenyl)carbamate (Standard) is the analytical standard of tert-Butyl Methyl(4-nitrophenyl)carbamate. This product is intended for research and analytical applications.
Cat. No.: HY-15992S
BIBF 1202- 13C,d3 is the 13C- and deuterium labeled BIBF 1202 (HY-15992). BIBF 1202 is the carboxylate metabolite of Nintedanib (HY-50904) which inhibits VEGFR2 kinase with an IC50 of 62 nM.
Cat. No.: HY-75697
CAS No.: 676326-36-6
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 5 is an impurity of Nintedanib (HY-50904).
Cat. No.: HY-Z0013
CAS No.: 1987887-92-2
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 7 is an impurity of Nintedanib (HY-50904).
Cat. No.: HY-Z0021
CAS No.: 90924-46-2
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 10 is an impurity of Nintedanib (HY-50904).
Cat. No.: HY-Z0086
CAS No.: 2410649-54-4
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 2 is an impurity of Nintedanib (HY-50904).
Cat. No.: HY-Z0127
CAS No.: 474020-88-7
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 8 is an impurity of Nintedanib (HY-50904).
Cat. No.: HY-Z0138
CAS No.: 121-95-9
Target:  

Drug Intermediate

Research Areas:  

Others

Nintedanib impurity 41 is an impurity of Nintedanib (HY-50904).